AstraZeneca gets CDSCO nod to conduct Phase III CT of antineoplastic FDCs drug Medical Dialogues Team24 May 2022 5:15 AM GMTNew Delhi: Suggesting to increase the number of subjects in clinical trial to 34, from the proposed 24 subjects in India, the Subject Expert Committee ...
Coronavirus: India supplies non-JnJ vaccine under Quad umbrella ruchika21 May 2022 4:30 AM GMTBagchi did not give numbers, but Indian foreign ministry data shows that India last month sent 200,000 doses of Covovax, a version of the Novavax...
Coronavirus: India supplies non-JnJ vaccine under Quad umbrella ruchika21 May 2022 4:30 AM GMTBagchi did not give numbers, but Indian foreign ministry data shows that India last month sent 200,000 doses of Covovax, a version of the Novavax...
AstraZeneca, RQ Biotechnology ink pact for monoclonal antibodies against coronavirus ruchika18 May 2022 9:06 AM GMTUnder the agreement, AstraZeneca has acquired an exclusive worldwide licence to develop, manufacture and commercialise mAbs against SARS-CoV-2.
AstraZeneca booster effective against severe COVID: UK study ruchika7 May 2022 4:30 AM GMTThe research supports the use of the AstraZeneca booster for protection against severe disease with COVID-19 in settings that have not yet offered...
AstraZeneca, Daiichi Sankyo get USFDA nod for Enhertu for earlier breast cancer use ruchika6 May 2022 11:38 AM GMTThe approval was granted under the FDA's Real-Time Oncology Review (RTOR) programme and converts the accelerated approval of Enhertu in later line...
GSK, SK bioscience seek nod for SKYCovione in South Korea ruchika1 May 2022 3:30 AM GMTSKYCovione is a self-assembled nanoparticle vaccine candidate targeting the receptor binding domain of the SARS-CoV-2 Spike protein for the parental...
Setback: AstraZeneca proposal to market, manufacture Olaparib rejected by CDSCO panel Medical Dialogues Team23 April 2022 11:33 AM GMTNew Delhi: In a major setback to AstraZeneca, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has...
AstraZeneca India rebrands Global Technology Centre as Global Innovation and Technology Centre ruchika8 April 2022 7:35 AM GMTThe rebranding marks the centre's evolution of capabilities, commitment to driving innovation and moving the company towards a digitally-enabled...
MoS Health Tells Rajya Sabha :Increase in Antibodies Post Covaxin Booster Dose Medical Dialogues Bureau31 March 2022 11:10 AM GMTNew Delhi: An ICMR study to examine the effect of Covaxin's booster dose has shown an increase in the levels of antibodies against SARS-CoV-2,...
AstraZeneca Evusheld recommended for approval in EU for prevention of COVID ruchika27 March 2022 4:00 AM GMTThe recommended dose of Evusheld in Europe is 150 mg of tixagevimab and 150mg of cilgavimab, administered as two separate sequential intramuscular...
Bristol Myers sues AstraZeneca over cancer-treatment patents MD Bureau19 March 2022 12:38 PM GMTBristol asked the Delaware court for an undisclosed amount of monetary damages.
